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Abstract
The aim of this study was to compare two different acellular scaffolds: natural and synthetic, for urinary conduit
construction and ureter segment reconstruction. Acellular aortic arch (AAM) and poly(L-lactide-co-caprolactone) (PLCL) were
used in 24 rats for ureter reconstruction in both tested groups. Follow-up period was 4 weeks. Intravenous pyelography,
histological and immunohistochemical analysis were performed. All animals survived surgical procedures. Patent uretero-
conduit junction was observed only in one case using PLCL. In case of ureter segment reconstruction ureters were patent in
one case using AAM and in four cases using PLCL scaffolds. Regeneration of urothelium layer and focal regeneration of
smooth muscle layer was observed on both tested scaffolds. Obtained results indicates that synthetic acellular PLCL
scaffolds showed better properties for ureter reconstruction than naturally derived acellular aortic arch.
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Introduction
The main indication for ureter reconstruction are iatrogenic
injuries, muscle invasive ureter cancer is rare [1,2]. The gold
standard for urinary diversion following radical cystectomy and
ureter segment reconstruction is use of the ileal conduit [3,4]. Use
of tissue engineering techniques for urinary conduit creation and
ureter segment reconstruction can eliminate most of complications
related to currently used procedures, and when combined with
laparoscopic approach can reduce time of surgery by 1.5–2 h and
increase patient survival rate [5].
Ideal material for ureteral conduit creation and ureter segment
reconstruction should be easily accessible, impermeable for urine,
non-immunogenic, guarantee future remodeling, and should
possess appropriate conditions for cell growth and migration
[6,7]. Many reports showed that scaffold preseeding with
autologous stem cells derived from adipose tissue or bone marrow
enhance vascularization and regeneration of reconstructed tissues,
but acellular scaffolds have a possibility to be applied into the clinic
[8,9]. Constructs of appropriate scaffold that will regenerate
structure of ureter by itself will be ideal solution to eliminate
necessity of autologous tissue biopsy. Such approach will be less
harmful for patients and will shorten procedure by elimination of
time necessary for cell culturing. Acellular scaffolds can be
promising as a potential ‘‘of-the-shelf’’ product.
Till now we have no clear answer what kind of material is the
best for ureter reconstruction. If such material will be discovered it
will have a great impact on medical ureteral reconstruction
procedures. The aim of the present study was to compare two
types of scaffolds for ureter reconstruction: naturally derived rat
acellular aortic arch (AAM) and electrospun nanofibrous scaffold
made of synthetic poly(L-lactide-co-caprolactone) (PLCL).
Naturally derived vascular grafts are composed of proteins,
glycosaminoglycans, different collagen types (I, III, IV, VI, VIII,
XV, XVIII), laminins, elastin, fibrilin, proteoglycans, vWF, and
other components which support cell adhesion, migration and
proliferation [10]. Disadvantages are different structure from
native tissue and cytotoxic induction after decellularization
procedure, and porous structure that can perfuse urine. These
factors may cause inflammation and disorder of cell colonization
[11,12]. Decellularization process, since its first use, is now more
precisely described and allows to obtain acellular scaffold not only
from tissues but also from whole organs like kidney [13–15].
Electrospun nanofibers are created when liquid jet of viscoelas-
tic fluid is subjected to a high electric field (0.121 kV/cm). In such
conditions a filament of polymer solution or melt starts to make
looping motion caused by a charge repulsion. This movement
creates very thin fibers (from several nm to about 2 mm) of the
polymer. These fibers form material of very special properties.
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They are very similar to Extracellular Collagen Matrix (fiber size
50–500 nm), they are treated by cells as their native environment.
Nonwoven nanofibrous membrane is colonized by the cells thus
they can form a ‘‘pseudo-tissue’’. If nanofibrous membrane is
created from biodegradable and biocompatible polymer (e.g.
poly(L-Lactide-co-caprolactone)) the material has no negative
impact on the cells – is gradually hydrolyzed by cells and replaced
by a native collagen. Aliphatic polyesters are special group of
polymers – they degrade in the environment of organism to create
natural metabolites or their non-toxic analogues. Most known and
used in surgery and tissue engineering are (co)polymers of lactic
acid. The final product of degradation of poly(lactic acid) is lactic
acid. Thick implants produce noticeable amounts of this acid
(pKa = 3.83) that can irritate surrounding tissue. Nanofibrous
implants have highly porous structure and contain far less material
than materials made of solid poly(lactic acid). There is a family of
polyesters – aliphatic polycarbonates that generate only very weak
carbonic acid and therefore they have limited impact on the tissue
irritation [16–18]. Polyesters are created de novo, no animal
material has to be used to synthesize them. They can be combined
with other compounds and it is possible to control their shape, size,
porosity, cell attachment, or biodegradability [19–21]. Disadvan-
tages are possibility of inflammation inducted by a too long
degradation time for PLCL [22,23].
Our experiment was divided into two stages. In the first stage,
urinary conduit construction was performed to test proximal
anastomosis of ureter with scaffold and to check continuity of
urinary conduit lumen. In the second stage reconstruction of
important clinically ureter segment defect was performed to test
proximal and distal anastomosis of ureter with scaffold and to
check passage of urine through reconstructed segment.
Materials and Methods
Scaffolds
Aortic arches were obtained from 12 donor Wistar rats. The
decellularization process involved aortic arch incubation at 4uC in
0.2% Triton X-100 (Sigma, Germany) and 26.5 mmol/L ammo-
nium hydroxide (Sigma, Germany) solution for 14 days. Aortic
arches were then washed in deionized water for 3 days and
disinfected by storage in phosphate buffered saline (PBS) with
antibiotics (PAA, Austria) until implantation. Acellularity was
confirmed by routine hematoxylin and eosin (HE) staining.
Dimensions of implanted scaffolds was: length 21 cm, diameter
–3–4 mm for PLCL and 2 mm for aortic arch.
Tubular nanofibrous scaffolds were produced using electrospin-
ning method. The electrospinning process has been described in
details elsewhere [24,25]. In our experiment, the spinning distance
was 20 cm, the electric potential was 15 kV, and the solution
throughput was 0.500 ml/h. A rotating brass rod (1000 rpm,
diameter of 4 mm) served as a nanofibrous mat collector. The
polymer used for electrospinning was poly(L-lactide-co-caprolac-
tone) (PLCL), which was composed of 70% L-lactide and 30%
caprolactone units and is known commercially as Purasorb 7015
(Purac - Corbion, Gorinchem, Netherlands). The electrospinning
solution was made of 9% polymer dissolved in a mixture of
solvents (chloroform+dimethylformamide, mass proportions 16:1).
A scanning electron microscopy analysis was performed to
visualize the biomaterial structure.
PLCL degradation test
Biomaterials were implanted into the rat abdomen. Ten Male
Wistar rats were anaesthetized with intraperitoneal sodium
pentobarbitone in dose 50 mg/kg on body weight. Post-operative
analgesia with opiate based pain killers was provided. All animals
survived the surgical protocol and in all cases the implantation sites
in surgical wounds healed without complications. Six weeks after
PLCL scaffold implantation rats were scarified, implanted
biomaterials were removed and prepared for electron microscopy
evaluation.
The samples were prepared with ‘regular’ ice-cold fixative with
2% paraformaldehyde (Sigma, Germany) and 2.5% glutaralde-
hyde (Sigma, Germany) in 0.1 M sodium cacodylate buffer,
pH 7.4 (Sigma, Germany), as was described earlier [26]. The
specimens were handled with the typical ice-cold fixative (see
above) post-fixed in 1% (w/v) OsO4 (Sigma, Germany) solution in
deionized water, dehydrated in an ethanol gradient, and encased
in epoxy resin (Epon 812, Sigma, Germany). Ultrathin (60 nm)
sections were prepared as described earlier [26]. Specimens were
examined in a transmission electron microscope (JEM-1200EX,
Jeol, Japan).
Cytotoxic assay
Both scaffolds were incubated in standard culture medium
DMEM Ham’s F12 (PAA, Austria) with 10% FBS and antibiotics
(Sigma, Germany) for 2 week in incubator (36uC, 5% CO2). Such
obtained conditioned medium was next added to the rat smooth
muscle cell line (CRL 2018, ATCC, USA) after 24 h incubation
on 24-well plate. Cells were seeded with density 56104 on each
well and cultured in standard culture medium. Cytotoxicity of
scaffolds was measured using MTT assay after 24 48, and 72 h
incubation with conditioned medium (in control with standard
medium). Results were presented as mean from ten independent
measurements.
Cell growth analysis
Acellular aortic arch scaffold was attached do the well of 6-weel
plate using needles, considering its small size. PLCL scaffold was
placed in inserts (Cell Crown, Scaffdex, Finland) which were next
placed in 24-well plate. Rat smooth muscle cell line (CRL2018,
ATCC, USA) were seeded on each scaffold with density 56105 on
1.9 cm2. Cell growth on outer scaffold surface was performed
using MTT assay (Sigma, Germany).
Surgical procedure
This experiment was approved by the Committee on the Ethics
of Animal Experiments of the University of Technology and Life
Science in Bydgoszcz, Poland (no. 3/2012). Twenty-four Wistar
rats (10 weeks old) were randomly divided into two equal groups
(12 rats on each), each group was additionally divided into two
equal subgroups (6 for aortic arch scaffold, 6 for nanofibrous
tubular scaffold).
Urinary conduit construction
The isolated right ureters were cut near the bladder. The distal
end of the acellular aortic arch scaffold (Group 1A) or nanofibrous
scaffold (Group 1B) scaffold was implanted into previously formed
channel in the muscle layer and fixed to the fascia and skin. The
ureters were anastomosed end-to-end to proximal end of the
scaffold using 8-0 non-absorbable sutures. No stenting of the
ureteral anastomosis or drainage was done.
Ureter segment reconstruction
In the middle part of right ureter 1 cm defect was replaced with
the acellular aortic arch scaffold (Group 2A) or nanofibrous
scaffold (Group 2B) anastomosed with ureter stumps by end-to-
end anastomosis using 8-0 non-absorbable sutures. Catheter (3 cm
Tissue Engineered Ureter
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length, 0,6 mm diameter, GALMED, Bydgoszcz, Poland) was
introduced into reconstructed ureter site on all follow-up period.
The follow up period was 4 weeks. The patency of the ureters
and conduits was assessed by intravenous pyelography at 4 weeks
using X-ray Actube Dental 5D2 with exposures at 60 kV and
6 mA.
Changes in kidney size
Evaluation of kidneys size on the operated side compared to
normal kidneys was performed on the basis of photographic
documentation (ImageJ, NIH, USA). Kidneys size was measured
by summing their length and width in 2D picture, results were
presented in percentage.
Histological and immunohistochemical analysis
The constructed specimens were fixed in 10% neutral buffered
formalin and embedded in paraffin. Cross-sections of the whole
reconstructed segments and kidneys were prepared. Histological
analysis with HE staining was performed. The connective tissue
components and muscle layer were stained according to Masson
staining.
For confirmation of smooth muscle layer regeneration immu-
nohistochemical analysis using anti-smooth muscle a-myosin
heavy chain (a-SMM, Abcam, Great Brittan). This analysis was
performed according to the procedure described previously [27].
Briefly, tissue sections were incubated with primary antibody
against a-SMM (dilution 1:400). After washing, the sections were
overlaid with peroxidase-conjugated anti-mouse secondary anti-
body (EnVision/HRP anti Mouse; Dako, Denmark). Stained
samples were analyzed using light microscopy by two independent
pathologists.
Statistical analysis
Cytotoxic differences between standard and conditioned medi-
um was evaluated using t-Student or Cochran-Cox. The
significance level p,0.05 was used as reliable.
In order to detect dependence between tested scaffolds and
reconstruction result, Fisher’s exact test and two fraction test were
used (Statistica 10.0, StatSoft, USA) because of small class
number. The significance level p,0.05 was used as reliable.
Results
Scaffolds
No remnants of cell debris were detected throughout the cross-
section of the aortic arches after decellularization (Fig. 1).
Scanning electron microscopy showed high porosity of decellular-
ized aortic arch scaffold built of submicron size filaments bundled
to form fiber of thickness ranged from 0.9 to 2.45 mm and wall
thickness 60–100 mm; multilayered structure of the wall was also
revealed. Electrospun nanofibrous scaffold had also high porosity
structure (ca. 78%), with smaller pores and higher fiber density
compared to aortic arch. Unlike in aortic arch, the fibers were not
formed of bundles. The fibers thickness of PLCL scaffold are
similar to that of aortic arch, and ranged from 0.81 to 2.15 mm.
The wall thickness is about 280 mm (Fig. 1).
PLCL degradation test
Six week after PLCL implantation into rat peritoneum tested
scaffolds covered with host tissue with well developed vascular
network (Fig. 2A–D). Specimen analyzed by ultrastructural
electron microscopy contained cells of proper shape. Absence of
macrophages and lymphocytes indicated absence of inflammatory
response. The majority of nanofibrous membrane was dissolved
during the specimen fixation, but with different level of integration
with tissue some residues are visible. Fig. 2E (arrow) shows
delicate bundles of collagen fibrils replacing degrading electrospun
membrane. Fig. 2F (nr-nanomaterial residue) shows the nanoma-
terial remains. The border between proliferating elements of
connective tissue and nanofibrous material is distinctly shown on
Fig. 2G (b-borders). Oval shaped cavities of different size are left
by dissolved material are visible in the regions of less advanced
tissue with material integration Fig. 2G (d). Collagen fibrils are
filling regular, oval-shaped niches. (Fig. 2G n-niche). Proper blood
vessels are formed in the nanomaterial (Fig. 2H v – blood vessel
lumen). The specimens contained proper cells, no inflammatory
response and pieces of nanomaterial on different stages of
biodegradation (Fig. 2E–H).
Cytotoxic assay
MTT assay showed no cytotoxic influence of both conditioned
media obtained after 24 and 48 h incubation with acellular aortic
arch and PLCL nanomaterial on CRL2018 cell line (Table 1).
Slight cytotoxic influence was observed after 72 h incubation with
conditioned medium obtained after incubation with PLCL
scaffold. Microscopic analysis showed no differences in cell
morphology after treatment with conditioned media compared
to control (Fig. 3).
Cell growth analysis
After 2 weeks of cell culture HE staining showed growth of cell
layers on both outer surfaces of tested scaffolds. Cells growth as a
monolayer in case of acellular aortic arch scaffold. In case of
PLCL scaffold cells created from one to several number of layers
and started to penetrate inside the scaffold (Fig. 3).
Surgical procedures
Urinary conduit construction. All animals survived the
surgical procedure. After the end of surgery urine leak from the
conduit was observed in all cases at the outside at skin level
(Fig. 4). Two rats in Group 1A and five rats in Group 1B
completed the follow-up period (Table 2). There were no
adhesions after the end of follow-up in all cases.
Aortic arch scaffold integrated better with native ureter than
nanofibrous scaffold in gross examination (Fig. 5D,E). However
the use of natural scaffold resulted in stenosis, obstruction and
urine flow inhibition within one week (3–8 days) after surgery. At
the end of follow up hydronephrosis and ureter extension were
observed (Fig. 6A). Nanofibrous scaffold, showed worse integra-
tion with ureter than natural scaffold (Fig. 5A). For one case (rat
no. 10) conduit resembled native ureter 28 days after surgery
(Fig. 5B). Patency of the conduits was observed in 3 cases from
Group 1B, but only in one case clear urine flow from conduit was
noticed (Table 2). In this case intravenous pyelography showed a
patent uretero-PLCL-conduit junction with mild hydronephrosis
and mild ureter extension compared to unsuccessful cases (Fig. 6B,
Fig. 7A,G).
Ureter segment reconstruction. All animals survived the
surgical procedure. Four rats in Group 2A and six rats in Group
2B completed the follow-up period (Table 3). In one case in Group
2A and in four cases in Group 2B urographic analysis showed
patent uretero-scaffold anastomosis (Table 3, Fig. 7B–F).
Macroscopic analysis showed hydronephrosis and ureter
extension in rats in which intravenous pielography showed lack
of visible urinary tract on X-ray images in two tested groups (2A
and 2B, Fig. 6C, D). In other cases, in which urographic analysis
showed patent uretero-scaffold anastomosis this side-effects were
less severe. (Fig. 7H–L). Acellular aortic arch scaffold integrate
Tissue Engineered Ureter
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very well with native ureter resembling its structure (Fig. 5F).
Integration of synthetic PLCL scaffold with native ureter was not
observed, similarly to lack of degradation of PLCL scaffold
(Fig. 5C). Overgrowth of connective tissue over the synthetic
scaffold was observed (Fig. 7L).
Both tested scaffolds have reduced their length by approxi-
mately 30% at the end of follow up. Catheters were find under
reconstructed segment, in the lower ureter part near the bladder.
Histological analysis
In Group 1 histological analysis of kidneys usually showed
intense purulent inflammatory infiltration with renal tubule
atrophy 28 days after surgery. In rat no. 10 this processes was
less severe. Only slight degenerative changes in renal tubule and
small focal inflammatory infiltration were observed. Less than
50% of renal tubules were enlarged (Fig. 8). In Group 2
inflammatory process with hydronephrosis was also observed.
Renal tubules were enlarged which was not correlated with
scaffold type and surgical procedure effectiveness (Fig. 8).
In Group 1, histological evaluation of aortic arch conduit
showed intense inflammatory infiltration with lack of epithelial and
smooth muscle layer regeneration. Tubular nanofibrous PLCL
scaffold showed better properties as a conduit. Visible multilayered
epithelium covering the PLCL conduit lumen and focal developed
smooth muscle layer were observed (Fig. 8). In Group 2 on both
scaffolds regeneration of urothelium and smooth muscle layer was
Figure 1. Macroscopic and scanning electron microscopy images of aortic arch and electrospun nanofibrous scaffolds.
doi:10.1371/journal.pone.0106023.g001
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observed. Inflammatory infiltration with fibrosis was also observed
(Fig. 8).
Regeneration of smooth muscle layer was confirmed by
immunohistochemical and Masson staining. In Group 1A
regeneration was not observed (Fig. 9A,D). In Group 1B intensive
regeneration of smooth muscle layer with high cell density was
observed. Creation of muscle bundles, migration of cells form
native ureter, cell migration inside the scaffold and round cells in
early growth phase were also observed (Fig. 9B,C,E,F). In Group 2
on both scaffold types regeneration was observed. Cell migration
form native ureter on scaffold surface, cell growth in monolayer,
chaotic layers of muscle cells and muscle bundles creation was
observed (Fig. 9G–L).
Statistical analysis
Fisher’s exact test have not detected dependency between
scaffold type and reconstruction result both in Group 1 and 2
(p = 0.09 and p = 0.12, respectively). In Group 1 important results
were obtained from two fraction analysis (p = 0.045), in Group 2
results were not significantly important (p = 0.06). Both statistical
analysis of scaffolds alone, without grouping, showed significantly
important results (p = 0.01) between scaffold type and reconstruc-
tion result favoring PLCL scaffold.
Discussion
In the present study we compared two different materials for
urinary conduit construction and ureter segment reconstruction:
natural rat acellular aortic arch and tubular nanofibrous scaffold
made of biodegradable synthetic polyester PLCL.
There are two main material factors that differ acellular aortic
arch from nanofibrous material. High porosity and wettability of
the biomaterial makes cell colonization and infiltration very facile,
but also enables infiltration of urine through the scaffold that
causes tissue irritation and is harmful to the cells. Low porosity and
wettability of the nanofibrous scaffold makes cell colonization
much harder (or even disables stable attachment of tissue to the
nanofibrous polyester scaffold), but also creates the barrier that is
impermeable to urine and isolates newly formed tissue from its
harmful influence. Thin layer of decellularized aortic arch enables
fast integration with the surrounding tissue, but also increases the
urine infiltration with its harmful consequences. Thick layer of the
biomaterial has very good insulating properties against urine
infiltration, yet thick layer of material is far harder to be digested
by cells and as a consequence can trigger tissue inflammation
caused by long time contact with a foreign body. The porosity,
wettability and thickness of the scaffold needs to be balanced for
the best performance [28].
Six week after implantation to peritoneum PLCL scaffold was
surrounded by developed omentum vascular network (Fig. 2A–D).
Analysis using ultrastructural electron microscopy suggest gradual
integration of tested membrane with rat tissue. The scaffold
niches, filled with Extracellular Collagen Matrix (ECM), are likely
to be the traces of degraded nanomaterial. Absence of cells of
improper structure or irregular pieces of membrane suggests good
integration of electrospun material with tissue. Bridges of collagen
Figure 2. PLCL degradation test. A–D – Macroscopic evaluation, tested scaffold was covered with host tissue with well developed vascular
network; E–H - Ultrastructural micrographs of specimen harvested from rat’s peritoneum 6 weeks after nanomaterial implantation. E - Arrow points
bundles of collagen; F – (nr – nanomaterial residue); G – (b – border between collagen and nanomaterial, c – collagen, d – dissolved nanomaterial, n –
niche filled with collagen); H - (v – blood vessel lumen).
doi:10.1371/journal.pone.0106023.g002
Table 1. Results of cytotoxic influence of conditioned media obtained after incubation with acellular aortic arch scaffold (AAM)
and poly(L-lactide-co-caprolactone) (PLCL) on rat smooth muscle cell line (CRL2018).
Incubation time Viability (%) compared to control
AAM PLCL
24 h 102.1615.2 (p = 0.76) 94.1615.2 (p = 0.13)
48 h 92.8619,8 (p = 0.40) 109.0617.3 (p = 0.83)
72 h 98.8+12.0 (p = 0.83) 91.066.5 (p = 0.002)
doi:10.1371/journal.pone.0106023.t001
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fibrils are connecting regions of ECM. They are growing through
nanomaterial showing its gradual integration with tissue. Fibro-
blasts surrounding the nanomaterial are producing collagen. The
collagen replaces biodegraded nanomaterial. This properties
suggests proper integration of tissue with electrospun nanomaterial
(Fig. 2E–H). According to Morita et all. [29] solid PLCL
completely degrades in vitro (in saline in 37uC) during one year
(comparing to 3–5 years for poly(L-lactide) and more than 5 years
for poly(caprolactone). In vivo degradation of thin PLCL spongy
implants was assessed by Jeong et all. [30]. They have found that
custom made PLCL (50% L-lactide, 50% e-caprolactone)
implanted subcutaneously and seeded with smooth muscle cells
had lost 19% of the original mass after 15 weeks. Number average
molecular mass have decreased to 23% of initial value and the cells
ingrown to the scaffold. The degradation occurred through
random scission of the polymer chain. Authors also concluded
that amorphic domains of PLCL have degraded faster than
crystalline domains of PLLA. Contemporary work of Thapsukhon
Figure 4. Effects of surgical procedure. A – End of urinary conduit reconstruction procedure, arrow marked site of end-to-end anastomosis; B –
Stoma, urine leakage form constructed urinary conduit directly after end of surgical procedure; C – End of ureter segment construction procedure,
arrow marked sites of end-to-end anastomosis.
doi:10.1371/journal.pone.0106023.g004
Figure 3. Cytotoxic effect of tested scaffolds on smooth muscle cell line. Cell morphology after treatment with conditioned media obtained
after incubation with both scaffold type and hemotoxylin-eozin (HE) staining of cells seeded on tested scaffolds surface.
doi:10.1371/journal.pone.0106023.g003
Tissue Engineered Ureter
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et all. [31] dealt with a model very similar to our works.
Microtubes made of custom made PLCL was electrospun to
produce microtubes for in vitro degradation assessment. Micro-
tubes made of PLCL (67% L-lactide, 33% e-caprolactone –
composition very close to commercial material used in our study)
have lost 29,8% of mass during in vitro 36 weeks degradation in
saline at 37uC. According to Bandyopadhyay et all. [32] sponges
made of 70/30 l-lactide/e-caprolactone copolymer (PLCL) seeded
with myoblasts undergone complete in vivo biodegradation 9
months after implantation.
In our study we used scaffolds alone, without seeded cells.
Nanofibrous scaffold showed better properties for urinary conduit
construction than acellular aortic arch scaffold but its integration
with native ureter was generally worse. PLCL was made of
hydrophobic polymer and was not specially treated to increase
hydrophilicity. Therefore it showed worse integration with ureter
than natural scaffold. Acellular aortic arch scaffold because of its
natural origin indicates very good integration with native ureter
but other properties, especially scaffold diameter, caused conduit
occlusion at the end-to-side anastomosis. Aortic arch have the
largest diameter in rat, that is why we choose this vascular graft for
experiment. Both scaffold types used in this experiment were
disinfected before implantation using PBS with antibiotic, as
previously described [33]. Conditioned media obtained from both
tested scaffolds were nontoxic after 24 and 48 h incubation with
smooth muscle cell line. Slight cytotoxic effect was observed only
after 72 h using PLCL conditioned medium, but cell growth
analysis together with PLCL degradation test showed that cells
growth well on PLCL surface starting to penetrate inside the
scaffold (Fig. 2, Fig. 3).
We used nonabsorbable sutures which served as a markers in
this experiment. Despite use of such sutures and short follow-up,
lack of stone formation inside the ureters and bladders were
observed. Other important aspect was stoma formation in Group
1. Flat stoma can be result of improper urine collection in the bag
and possible problem with the bag sticking to skin. To prevent the
urine leakage we performed a stoma in the form of ‘‘chimney’’
(part of scaffold protruded outside the skin) because the diameter
was too small to form nipple stoma in rat.
Until 2012 only one paper about urinary conduit construction
using tissue engineering methods was available [33]. In this
work Drewa used SIS seeded and unseeded with 3T3 fibroblast
cell line for urinary conduit creation. In three cases conduits
were patent, seeding with 3T3 cells did not improve the results
obtained, in this group inflammation process was more severe
than in group with unseeded scaffold. In recent years another
group described their attempts to make artificial urinary conduit
using tissue engineering. Geutjes et al. [34] used scaffold built
from collagen type I and VyproII synthetic mesh for urinary
conduit construction in 10 female pigs (4 unseeded scaffolds and
6 seeded with urothelial cells), but no differences between
seeded and unseeded scaffolds were observed. Another study
was performed on 30 rabbits using bladder acellular matrix
(BAM) seeded or unseeded (control) with urothelial cells. In this
study bladder was removed and two ureters were sutured to
constructed conduit [35]. All 24 rabbits with cell seeded BAM
survived follow-up. Multilayered epithelium covering the conduit
lumen and lack of severe complications were noticed. In control
group (n = 6) 4 rabbits died until 1 month after surgery, in two
other cases fistula has appeared. Lack of epithelial layer
regeneration was observed. Similar study was presented recently
by the same group [36].
One of the first attempt of ureter regeneration was performed
on dogs using human or monkey umbilical cord treated with
cyclophosphamide to remove morphological blood elements
(leukocytes). Only in one case good results in long follow-up
Figure 5. Integration of scaffolds with native ureters – macroscopic evaluation. A, C – lack of integration of electrospun nanofibrous
scaffold; B – good integration of electrospun nanofibrous scaffold, it is impossible to find anastomosis site; D-F – good integration of aortic arch
scaffold. C – conduit, U – ureter. Arrows marked sites of anastomosis.
doi:10.1371/journal.pone.0106023.g005
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Figure 6. Macroscopic analysis of unsuccessful ureter regeneration in both tested groups. Kidney hydronephrosis and ureter extension
can be observed. AAM – acellular aortic arch scaffold, PLCL - poly(L-lactide-co-caprolactone). Reconstructed segments are marked with arrows.
doi:10.1371/journal.pone.0106023.g006
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period (3 years) were obtained, in other cases different degree of
renal failure was observed [37]. Other acellular natural scaffolds
like SIS, decellularized ureter, scaffolds derived from vessels or
synthetic materials like Gore-Tex (polytetrafluoroethylene) were
used [38–44]. All this experiments failed because of complica-
tions or not significantly important segment reconstruction
(0.3 mm).
The important aspect in ureter regeneration is to maintain
ureter continuity. Small tissue section in reconstructed segment
can stimulate cell layers regeneration on scaffold. Additionally
peristaltic wave is not interrupted. Promising results obtained
after using onlay technique shows how difficult is regeneration
of whole-diameter ureter segment [45–49].
Figure 7. Successful ureter regeneration in all tested groups. A–F – urographic analysis, G–L – macroscopic analysis. A, G – urinary conduit
construction using PLCL; B, H – ureter segment reconstruction using AAM, C–F, I–L - ureter segment reconstruction using PLCL. AAM – acellular aortic
arch scaffold, PLCL - poly(L-lactide-co-caprolactone). Reconstructed segments are marked with arrows.
doi:10.1371/journal.pone.0106023.g007
Table 3. Results of ureter segment reconstruction using acellular aortic arch and electrospun nanofibrous scaffolds.
No. Time (day) End of experiment CE Macroscopic evaluation
Upper urinary tract Reconstructed ureter segment Kidney*
Group 2A – acellular aortic arch (AAM)
13 1 Death – – – –
14 28 End of follow-up Lack Extended Patent 125
15 12 Death – Extended Patent 116
16 28 End of follow-up Present Extended Patent 106
17 28 End of follow-up Lack Extended Patent 150
18 28 End of follow-up Lack Extended Patent 141
Group 2B – poly(L-lactide-co-caprolactone) - PLCL
19 28 End of follow-up Lack Extended Patent 128
20 28 End of follow-up Lack Extended Patent 139
21 28 End of follow-up Present Extended Patent 119
22 28 End of follow-up Present Normal Patent 123
23 28 End of follow-up Present Extended Patent 121
24 28 End of follow-up Present Extended Patent 118
Good functional results relating to all mentioned aspects (reconstructed segment, ureter, kidney) were bold. (CE – contrast excretion, Kidneys* - changes in kidneys size
(in percentage) on the operated side compared to normal kidneys).
doi:10.1371/journal.pone.0106023.t003
Tissue Engineered Ureter
PLOS ONE | www.plosone.org 10 August 2014 | Volume 9 | Issue 8 | e106023
Use of appropriate scaffold can stimulate its remodeling. In
our study urothelium regeneration was observed on both tested
scaffolds. Regeneration of smooth muscle was confirmed by
immunohistochemical and Masson staining. The same effect was
observed when SIS was used. Liao et al. showed lack of
epithelium regeneration on unseeded BAM [35,36]. Our
experiment with BAM used for bladder regeneration showed
urothelium regeneration on unseeded scaffold, but it has to be
emphasized that urothelial layer growth is not an urinary tract
regeneration [8]. Moreover, numerous clinical trials concerning
bladder reconstruction proved that urothelium self-regenerates
completely, migrating from ureters even after radical cystectomy
[50,51]. In our opinion scaffold preseeding only with urothelial
cells is not necessary, especially for small scaffold such as used
for urinary conduit creation because urothelium can easy self-
regenerate from surrounding tissue. We think, that the
important fact is provide scaffold protection from urine leakage
[28].
Figure 8. Histological changes in kidneys and tissue layer regeneration on ureter segments in both tested groups. RG-renal glomeruli,
RT-renal tubules, E-epithelial layer, SM-smooth muscle layer. AAM – acellular aortic arch scaffold, PLCL - poly(L-lactide-co-caprolactone). Magnification
was placed in right corner of images.
doi:10.1371/journal.pone.0106023.g008
Figure 9. Confirmation of smooth muscle regeneration on both tested scaffolds by immunohistochemical (A–C, G–I) and Masson
(D–F, J–L) analysis. A, D, F – Lack of smooth muscle layer regeneration. B, C, H, J–L – smooth muscle layer regeneration on both scaffold type and
all tested groups. C, G, I – migration of smooth muscle cells form native ureter (arrows) to AAM and PLCL scaffolds. (Light microscopy). AAM –
acellular aortic arch scaffold, PLCL - poly(L-lactide-co-caprolactone).
doi:10.1371/journal.pone.0106023.g009
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Conclusions
This experiment showed that construction of tissue engineered
urinary conduit and ureter segment regeneration is possible.
Electrospun nanofibrous scaffolds made of PLCL copolymer
showed better properties than naturally derived aortic arch.
Limitation of this study was small number of animals in each tested
group, small animal model and short follow-up. On the other side
rat is suitable animal model for experimental study for scaffolds
properties.
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Early experience in reconstruction of long ureteral strictures with allogenic
amniotic membrane. Int J Urol 14: 607–610.
48. Liatsikos EN, Dinlenc CZ, Kapoor R, Bernardo NO, Pikhasov D, et al. (2001)
Ureteral reconstruction: small intestine submucosa for the management of
strictures and defects of the upper third of the ureter. J Urol 165: 1719–1723.
49. Zhang J, Gu GL, Liu GH, Jiang JT, Xia SJ, et al. (2012) Ureteral reconstruction
using autologous tubular grafts for the management of ureteral strictures and
defects: an experimental study. Urol Int 88: 60–65.
50. Tsulukidze A, Murvanidze D, Dvali R, Ivashchenko G (1964) Formation of a
bladder by a plastic shell after total cystectomy. Br J Urol 36: 102–105.
51. Bohne AW, Urwiller KL (1957) Experience with urinary bladder regeneration.
J Urol 77: 725–732.
Tissue Engineered Ureter
PLOS ONE | www.plosone.org 13 August 2014 | Volume 9 | Issue 8 | e106023
